Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Aristeromycin SCHEMBL10353292 | 1.00 | AHCY (1.00) | AHCYADORA2B | |
| Aristeromycin SCHEMBL12280589 | 1.00 | AHCY (1.00) | AHCYADORA2B | |
| Aristeromycin SCHEMBL10353291 | 1.00 | AHCY (1.00) | AHCYADORA2B | |
| Aristeromycin SCHEMBL14515457 | 1.00 | AHCY (1.00) | AHCYADORA2B | |
| Aristeromycin SCHEMBL29695815 | 1.00 | AHCY (1.00) | AHCYADORA2B | |
| Aristeromycin SCHEMBL12173988 | 1.00 | AHCY (1.00) | AHCYADORA2B | |
| Aristeromycin SCHEMBL9820408 | 1.00 | AHCY (1.00) | AHCYADORA2B | |
| Aristeromycin SCHEMBL12157242 | 1.00 | AHCY (1.00) | AHCYADORA2B | |
| Aristeromycin SCHEMBL692209 | 1.00 | AHCY (1.00) | AHCYADORA2B | |
| SCHEMBL15297972 | 0.99 | AHCY (0.97) | AHCYADORA2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230302003-A1 | COMPOSITIONS AND METHODS FOR TREATING A CORONAVIRUS INFECTION | ANTIRNA INCORPORATED | 2023-09-28 | — | — | US | disclosed |
| EP-0684822-B1 | CARBOCYCLIC DEOXYGUANOSINE ANALOGS FOR THE TREATMENT OF VIRAL INFECTIONS | SOUTHERN RES INST (US) | 2002-05-08 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230302003-A1 | COMPOSITIONS AND METHODS FOR TREATING A CORONAVIRUS INFECTION | AHCY, AHCYL1, BHMT | AHCY 1/4885ADORA2B 1263/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.